JACC:晚期心衰患者的成纤维化一定程度上可逆

2019-05-13 不详 MedSci原创

间质纤维化是导致心衰患者收缩和舒张功能不全的重要原因之一,而其依赖于纤维母细胞到肌成纤维细胞(MyoFb)的激活和分化。近期的临床研究表明晚期心衰的纤维化是不可逆的。本研究的目的旨在评估晚期心衰MyoFb的分化程度。本研究从因缺血性心脏病或扩张型心肌病心脏移植患者的左室中分离出成纤维细胞,置于培养基中培养4-8天。细胞表型的鉴定包括功能实验、免疫染色和分化标志物的表达量检测。分析结果显示,心衰患者

间质纤维化是导致心衰患者收缩和舒张功能不全的重要原因之一,而其依赖于纤维母细胞到肌成纤维细胞(MyoFb)的激活和分化。近期的临床研究表明晚期心衰的纤维化是不可逆的。本研究的目的旨在评估晚期心衰MyoFb的分化程度。

本研究从因缺血性心脏病或扩张型心肌病心脏移植患者的左室中分离出成纤维细胞,置于培养基中培养4-8天。细胞表型的鉴定包括功能实验、免疫染色和分化标志物的表达量检测。分析结果显示,心衰患者的间质纤维化很明显,且存在MyoFb的激活,组织的转化生长因子(TGF)-β1、赖氨酸氧化酶、骨膜蛋白和骨桥蛋白表达水平升高,从心衰患者分离的成纤维细胞主要由MyoFb组成,且高表达促纤维化的细胞因子,且TGF-β1通路被激活。抑制TGF-β1受体激酶可促进心衰患者成纤维细胞的去分化,并将促纤维化的细胞因子降至非心衰水平。

研究结果显示,晚期心衰患者的肌成纤维细胞分化程度不一,在一定程度上是可逆的。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2029139, encodeId=b57a20291395b, content=<a href='/topic/show?id=d01e5982936' target=_blank style='color:#2F92EE;'>#晚期心衰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59829, encryptionId=d01e5982936, topicName=晚期心衰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Nov 02 16:20:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854385, encodeId=e37f1854385b2, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Mar 17 04:20:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326206, encodeId=1aba1326206ca, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373444, encodeId=41e313e3444ab, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2029139, encodeId=b57a20291395b, content=<a href='/topic/show?id=d01e5982936' target=_blank style='color:#2F92EE;'>#晚期心衰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59829, encryptionId=d01e5982936, topicName=晚期心衰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Nov 02 16:20:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854385, encodeId=e37f1854385b2, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Mar 17 04:20:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326206, encodeId=1aba1326206ca, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373444, encodeId=41e313e3444ab, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=)]
    2020-03-17 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=2029139, encodeId=b57a20291395b, content=<a href='/topic/show?id=d01e5982936' target=_blank style='color:#2F92EE;'>#晚期心衰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59829, encryptionId=d01e5982936, topicName=晚期心衰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Nov 02 16:20:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854385, encodeId=e37f1854385b2, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Mar 17 04:20:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326206, encodeId=1aba1326206ca, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373444, encodeId=41e313e3444ab, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2029139, encodeId=b57a20291395b, content=<a href='/topic/show?id=d01e5982936' target=_blank style='color:#2F92EE;'>#晚期心衰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59829, encryptionId=d01e5982936, topicName=晚期心衰)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b78f2500065, createdName=12498761m56暂无昵称, createdTime=Sat Nov 02 16:20:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854385, encodeId=e37f1854385b2, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Tue Mar 17 04:20:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326206, encodeId=1aba1326206ca, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373444, encodeId=41e313e3444ab, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Wed May 15 01:20:00 CST 2019, time=2019-05-15, status=1, ipAttribution=)]

相关资讯

JACC:利伐沙班联合阿司匹林可减少肾功能不全患者的不良事件风险

慢性肾脏疾病会增加出血和缺血性心脏病的风险,本研究的目的旨在评估双重抗血栓形成药物对血管疾病伴或不伴中度肾功能不全患者的风险和利益影响。本研究纳入了COMPASS临床试验中的27395名慢性冠心病或外周动脉疾病患者,其中21111名患者的基线肾小球滤过率(GFR)≥60 ml/min,6276名患者GFR<60 ml/min。无论是主要终点事件(心源性死亡,心梗或卒中)还是主要出血事件,在伴

JACC:呼吸系统疾病与心血管发病呈独立相关性!

呼吸疾病与心血管病的相关性尚不清楚,本研究的目的旨在评估慢阻肺(COPD)、哮喘、间质性肺病(ILD)与心血管疾病的相关性。本研究纳入了2000-2013年来自7个医学中心的呼吸系统疾病患者,包括31646名COPD、60424名哮喘和1662名ILD患者,经过平均2968182人年时间的随访,发现COPD与缺血性心脏病、心衰、房颤和外周血管疾病呈独立相关性,且所有这些均与全因死亡率的增高相关,哮

JACC:先心病孕妇分娩时的不良事件风险明显更高

患有先心病的孕妇在分娩时发生不良事件的风险会更高,本研究的目的旨在评估和比较患有先心病孕妇和不患有先心病孕妇分娩时发生的不良心血管、产科和胎儿结局。本研究纳入了美国2008-2013年期间22881691名孕妇,其中17729名患有先心病(77.5/100000),与非先心病孕妇相比,先心病孕妇的住院时间和费用更高,并发症的发病率也更高,包括肺动脉高压(aOR: 193.8; 95% [CI]:

盘点:JACC五月第一期研究一览

1.经导管二尖瓣修复术能改善心衰伴二尖瓣反流患者的健康状况<

J Hypertens:高血压和多种心血管危险因素会增加视网膜静脉阻塞的风险

由此可见,心血管危险因素比RVO存在的其他危险因素更重要。增加任何一个额外的危险因素,RVO的风险增加约40%,增加任何一个额外的心血管危险因素风险增加70%。